Annual Accounts Receivable
$229.58 M
+$13.41 M+6.20%
December 31, 2023
Summary
- As of February 7, 2025, ALKS annual accounts receivable is $229.58 million, with the most recent change of +$13.41 million (+6.20%) on December 31, 2023.
- During the last 3 years, ALKS annual accounts receivable has fallen by -$45.57 million (-16.56%).
- ALKS annual accounts receivable is now -26.70% below its all-time high of $313.19 million, reached on December 31, 2021.
Performance
ALKS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$367.21 M
+$796.00 K+0.22%
September 30, 2024
Summary
- As of February 7, 2025, ALKS quarterly accounts receivable is $367.21 million, with the most recent change of +$796.00 thousand (+0.22%) on September 30, 2024.
- Over the past year, ALKS quarterly accounts receivable has increased by +$137.63 million (+59.95%).
- ALKS quarterly accounts receivable is now at all-time high.
Performance
ALKS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
ALKS Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.2% | +60.0% |
| 3 y3 years | -16.6% | +49.4% |
| 5 y5 years | -21.4% | +49.4% |
ALKS Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.7% | +6.2% | at high | +69.9% |
| 5 y | 5-year | -26.7% | +6.2% | at high | +69.9% |
| alltime | all time | -26.7% | +7114.0% | at high | >+9999.0% |
Alkermes Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $367.21 M(+0.2%) |
| Jun 2024 | - | $366.42 M(+16.0%) |
| Mar 2024 | - | $315.85 M(+37.6%) |
| Dec 2023 | $229.58 M(+6.2%) | $229.58 M(-32.0%) |
| Sep 2023 | - | $337.70 M(+1.0%) |
| Jun 2023 | - | $334.48 M(+24.3%) |
| Mar 2023 | - | $269.18 M(+24.5%) |
| Dec 2022 | $216.17 M(-31.0%) | $216.17 M(-15.9%) |
| Sep 2022 | - | $257.17 M(+4.6%) |
| Jun 2022 | - | $245.84 M(-1.6%) |
| Mar 2022 | - | $249.94 M(-20.2%) |
| Dec 2021 | $313.19 M(+13.8%) | $313.19 M(+8.3%) |
| Sep 2021 | - | $289.16 M(-2.8%) |
| Jun 2021 | - | $297.36 M(+22.1%) |
| Mar 2021 | - | $243.51 M(-11.5%) |
| Dec 2020 | $275.14 M(+7.0%) | $275.14 M(+3.6%) |
| Sep 2020 | - | $265.64 M(+11.9%) |
| Jun 2020 | - | $237.39 M(-3.8%) |
| Mar 2020 | - | $246.72 M(-4.0%) |
| Dec 2019 | $257.09 M(-12.0%) | $257.09 M(+2.7%) |
| Sep 2019 | - | $250.23 M(-4.2%) |
| Jun 2019 | - | $261.23 M(+17.2%) |
| Mar 2019 | - | $222.81 M(-23.8%) |
| Dec 2018 | $292.22 M(+25.1%) | $292.22 M(+16.5%) |
| Sep 2018 | - | $250.91 M(-1.7%) |
| Jun 2018 | - | $255.23 M(+19.2%) |
| Mar 2018 | - | $214.16 M(-8.3%) |
| Dec 2017 | $233.59 M(+22.2%) | $233.59 M(+12.6%) |
| Sep 2017 | - | $207.54 M(+3.9%) |
| Jun 2017 | - | $199.71 M(+13.2%) |
| Mar 2017 | - | $176.49 M(-7.6%) |
| Dec 2016 | $191.10 M(+40.3%) | $191.10 M(+7.7%) |
| Sep 2016 | - | $177.45 M(-4.1%) |
| Jun 2016 | - | $185.01 M(+32.3%) |
| Mar 2016 | - | $139.81 M(+2.7%) |
| Dec 2015 | $136.19 M | $136.19 M(-3.4%) |
| Sep 2015 | - | $140.99 M(+3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $135.78 M(-4.4%) |
| Mar 2015 | - | $141.98 M(-6.3%) |
| Dec 2014 | $151.55 M(+13.0%) | $151.55 M(+5.5%) |
| Sep 2014 | - | $143.69 M(+3.1%) |
| Jun 2014 | - | $139.32 M(+13.1%) |
| Mar 2014 | - | $123.15 M(+2.2%) |
| Dec 2013 | $134.15 M(+7.7%) | - |
| Sep 2013 | - | $120.45 M(-7.8%) |
| Jun 2013 | - | $130.58 M(+4.8%) |
| Mar 2013 | $124.62 M(+29.3%) | $124.62 M(+4.0%) |
| Dec 2012 | - | $119.83 M(+24.3%) |
| Mar 2012 | $96.38 M(+319.6%) | $96.38 M(+319.6%) |
| Mar 2011 | $22.97 M(-51.4%) | $22.97 M(-14.0%) |
| Dec 2008 | - | $26.71 M(-25.9%) |
| Sep 2008 | - | $36.05 M(+13.7%) |
| Jun 2008 | - | $31.70 M(-32.9%) |
| Mar 2008 | $47.25 M(-15.7%) | $47.25 M(+17.4%) |
| Dec 2007 | - | $40.26 M(-8.3%) |
| Sep 2007 | - | $43.88 M(-34.3%) |
| Jun 2007 | - | $66.78 M(+19.1%) |
| Mar 2007 | $56.05 M(+40.8%) | $56.05 M(-10.2%) |
| Dec 2006 | - | $62.38 M(-3.0%) |
| Sep 2006 | - | $64.28 M(+55.5%) |
| Jun 2006 | - | $41.35 M(+3.9%) |
| Mar 2006 | $39.80 M(+111.5%) | $39.80 M(+19.1%) |
| Dec 2005 | - | $33.41 M(+40.1%) |
| Sep 2005 | - | $23.85 M(-14.3%) |
| Jun 2005 | - | $27.82 M(+47.9%) |
| Mar 2005 | $18.82 M(+491.2%) | $18.82 M(+104.2%) |
| Dec 2003 | - | $9.21 M(-52.0%) |
| Dec 2001 | - | $19.19 M(-6.0%) |
| Sep 2001 | - | $20.42 M(-36.6%) |
| Dec 2000 | - | $32.22 M(+4.5%) |
| Sep 2000 | - | $30.85 M(+0.8%) |
| Jun 2000 | - | $30.60 M(+861.5%) |
| Mar 2000 | $3.18 M | $3.18 M(-78.0%) |
| Sep 1997 | - | $14.48 M(+329.8%) |
| Dec 1996 | - | $3.37 M |
FAQ
- What is Alkermes annual accounts receivable?
- What is the all time high annual accounts receivable for Alkermes?
- What is Alkermes annual accounts receivable year-on-year change?
- What is Alkermes quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Alkermes?
- What is Alkermes quarterly accounts receivable year-on-year change?
What is Alkermes annual accounts receivable?
The current annual accounts receivable of ALKS is $229.58 M
What is the all time high annual accounts receivable for Alkermes?
Alkermes all-time high annual accounts receivable is $313.19 M
What is Alkermes annual accounts receivable year-on-year change?
Over the past year, ALKS annual accounts receivable has changed by +$13.41 M (+6.20%)
What is Alkermes quarterly accounts receivable?
The current quarterly accounts receivable of ALKS is $367.21 M
What is the all time high quarterly accounts receivable for Alkermes?
Alkermes all-time high quarterly accounts receivable is $367.21 M
What is Alkermes quarterly accounts receivable year-on-year change?
Over the past year, ALKS quarterly accounts receivable has changed by +$137.63 M (+59.95%)